Identification of Therapeutic Targets and Molecular Markers for Glioblastoma Stem Cells.

Kulkarni, Shreya.
2016

Abstract: Glioblastoma Multiforme (GBM) is the most common type of malignant brain cancer with a median survival of only 14 months post diagnosis. The current standard of care for all the patients is maximal surgical resection followed by radiation and chemotherapy with temozolomide, a DNA alkylating agent. This treatment reduces the tumor bulk, but is not curative as recurrence is very common. Th... read more

Subjects
Sackler School of Graduate Biomedical Sciences Department of Cell, Molecular and Developmental Biology.
Permanent URL
http://hdl.handle.net/10427/010943
ID: tufts:20416
To Cite: DCA Citation Guide